Johnson Investment Counsel Inc Catalent, Inc. Transaction History

Johnson Investment Counsel Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $1,908 - $3,118	42 Added 0.19%	22,739 $1.49 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $517,375 - $1.01 Million	12,500 Added 122.59%	22,697 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $506 - $791	-7 Reduced 0.07%	10,197 $738,000
Q1 2022 May 11, 2022	BUY	$94.19 - $124.49 $659 - $871	7 Added 0.07%	10,204 $1.13 Million
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $9,532 - $10,990	-95 Reduced 0.92%	10,197 $1.1 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $9,135 - $11,274	90 Added 0.88%	10,292 $1.08 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $632,328 - $804,102	-8,693 Reduced 46.01%	10,202 $874,000
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $35,918 - $59,121	-748 Reduced 3.81%	18,895 $1.39 Million
Q1 2020 May 20, 2020	SELL	$36.95 - $62.95 $169,970 - $289,570	-4,600 Reduced 18.97%	19,643 $1.02 Million
Q4 2019 Feb 13, 2020	BUY	$47.06 - $56.64 $56,142 - $67,571	1,193 Added 5.18%	24,243 $1.37 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $365,118 - $504,153	-9,300 Reduced 28.75%	23,050 $1.25 Million
Q1 2019 May 13, 2019	SELL	$29.84 - $43.92 $447 - $658	-15 Reduced 0.05%	32,350 $1.31 Million
Q4 2018 Feb 13, 2019	BUY	$29.95 - $46.34 $969,331 - $1.5 Million	32,365 New	32,365 $1.01 Million

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.